期刊
ACS CHEMICAL NEUROSCIENCE
卷 13, 期 12, 页码 1697-1713出版社
AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.2c00172
关键词
Alzheimer's disease; necroptosis; RIPK1; RIPK3; MLKL; therapy
资金
- National Key R&D Program of China [2021YFA1302200]
- National Natural Science Foundation of China [82022065, 82073696, 81872791, U20A20136]
- Shanghai Shuguang Project [21SG038]
- Scientific and Technological Innovation Project of Shanghai [21S11900800]
- Key Research and Development Program of Ningxia [2019BFG02017, 2021BEG03103]
- West Light Foundation of the Chinese Academy of Sciences [XAB2020YW15]
This article summarizes the potential role of necroptosis in Alzheimer's disease progression and explores the therapeutic capacity of targeting necroptosis for AD patients.
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder featured by memory loss and cognitive default. However, there has been no effective therapeutic approach to prevent the development of AD and the available therapies are only to alleviate some symptoms with limited efficacy and severe side effects. Necroptosis is a new kind of cell death, being regarded as a genetically programmed and regulated pattern of necrosis. Increasing evidence reveals that necroptosis is tightly related to the occurrence and development of AD. This review aims to summarize the potential role of necroptosis in AD progression and the therapeutic capacity of targeting necroptosis for AD patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据